Clinical Trials Browser

Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Flatulence, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT05605964 2025-08-17

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

Phase 3 Completed

387 enrolled

Genitourinary

Prostatic Neoplasms

NCT05458856 2025-07-25

TriptoSwitch

Phase 3 Completed

147 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT05547386 2025-07-18

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Phase 3 Completed

163 enrolled 3 charts

Genitourinary

Prostatic Neoplasms

NCT04742361 2025-07-15

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Phase 3 Completed

136 enrolled

Genitourinary

Prostatic Neoplasms

NCT04100018 2025-06-12

CheckMate 7DX

Phase 3 Completed

1,030 enrolled 25 charts

Genitourinary

Prostatic Neoplasms

NCT03072238 2025-06-06

IPATential150

Phase 3 Completed

1,101 enrolled 35 charts

Genitourinary

Prostatic Neoplasms

NCT00667069 2025-06-05

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Phase 3 Completed

424 enrolled

Genitourinary

Prostatic Neoplasms

NCT03834519 2025-05-18

KEYLYNK-010

Phase 3 Completed

793 enrolled 23 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT01220869 2025-04-13

A Study of Degarelix in Taiwanese Patients With Prostate Cancer

Phase 3 Completed

110 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02288247 2025-04-08

PRESIDE

Phase 3 Completed

688 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Phase 3 Completed

806 enrolled 32 charts

Genitourinary

Prostatic Neoplasms

NCT00887198 2025-02-04

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 3 Completed

1,088 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT01715285 2025-02-04

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

Phase 3 Completed

1,209 enrolled 16 charts 2 FDA

Genitourinary

Prostatic Neoplasms

NCT03103321 2025-01-27

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Phase 3 Completed

158 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT03511664 2025-01-13

VISION

Phase 3 Completed

861 enrolled 39 charts 2 FDA

Genitourinary

Prostatic Neoplasms

NCT02220829 2024-12-09

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Phase 3 Completed

148 enrolled

Genitourinary

Prostatic Neoplasms

NCT01964170 2024-10-31

A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer

Phase 3 Completed

234 enrolled

Genitourinary

Prostatic Neoplasms

NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Phase 3 Completed

261 enrolled 12 charts

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

NCT01272050 2024-08-28

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Phase 3 Completed

350 enrolled

Genitourinary

Prostatic Neoplasms

NCT04676334 2024-05-07

CATCH-R

Phase 3 Completed

34 enrolled 9 charts

GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Male, Ovarian Neoplasms, Prostatic Neoplasms

NCT04644822 2024-02-07

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Phase 3 Completed

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT04887506 2024-01-16

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Phase 3 Completed

107 enrolled 20 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT01394263 2024-01-02

Study of Histrelin Subdermal Implant in Patients With Prostate Cancer

Phase 3 Completed

59 enrolled

Genitourinary

Prostatic Neoplasms

NCT01697384 2024-01-02

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

Phase 3 Completed

138 enrolled

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT03001869 2023-11-27

68Ga-PSMA PET/CT in Prostate Cancer

Phase 3 Completed

540 enrolled

Genitourinary

Prostatic Neoplasms

NCT00541047 2023-11-13

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

Phase 3 Completed

4,236 enrolled

GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT05197257 2023-11-13

68Ga-PSMA-11 PET in Patients With Prostate Cancer

Phase 3 Completed

39 enrolled 7 charts

Genitourinary

Prostatic Neoplasms

NCT00942331 2023-10-16

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Phase 3 Completed

506 enrolled 13 charts

Genitourinary

Carcinoma, Transitional Cell, Prostatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00664456 2023-07-24

SHIP0804

Phase 3 Completed

421 enrolled

Genitourinary

Prostatic Neoplasms

NCT02015871 2023-06-18

PandaExtension

Phase 3 Completed

206 enrolled

Genitourinary

Prostatic Neoplasms

NCT00027859 2023-06-15

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Phase 3 Completed

Genitourinary

Prostatic Neoplasms

NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

282 enrolled

Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT02659527 2023-06-15

PET/MRI in Patients With Suspected Prostate Cancer

Phase 3 Completed

220 enrolled

Genitourinary

Prostatic Neoplasms

NCT01238172 2023-03-21

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

Phase 3 Completed

478 enrolled 11 charts

Genitourinary

Prostatic Neoplasms